Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome

Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase

(2020) David Mengel et al.   Alzheimers Research & Therapy

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

(2019) Carla M. Startin et al.   Alzheimers Research & Therapy

Plasma Neurofilament Light and Alzheimer’s Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)

(2019) Michael S. Rafii et al.   JOURNAL OF ALZHEIMERS DISEASE

Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis

(2019) Mei Jin et al.   Frontiers in Aging Neuroscience

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

(2018) Andre Strydom et al.   Alzheimers Research & Therapy

Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues

(2018) Sid E. O'Bryant et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

(2018) Juan Fortea et al.   LANCET NEUROLOGY

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

(2018) Piotr Lewczuk et al.   Alzheimers Research & Therapy

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease

(2018) Raquel Sánchez-Valle et al.   Alzheimers Research & Therapy

PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)

(2017) Michael S. Rafii et al.   JOURNAL OF ALZHEIMERS DISEASE

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

(2017) Harutsugu Tatebe et al.   Molecular Neurodegeneration

Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome

(2017) Sigan L. Hartley et al.   NEUROBIOLOGY OF AGING

Plasma neurofilament light chain levels in Alzheimer’s disease

(2017) Wenjun Zhou et al.   NEUROSCIENCE LETTERS

Increased levels of plasma total tau in adult Down syndrome

(2017) Takashi Kasai et al.   PLoS One

Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients

(2016) Gemma Currie et al.   CURRENT HYPERTENSION REPORTS

Plasma tau in Alzheimer disease

(2016) Niklas Mattsson et al.   NEUROLOGY

Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration

(2016) Henrik Zetterberg   NEURON

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease

(2016) Matthew R. Brier et al.   Science Translational Medicine